** = Publications listed in SCI/SSCI/Pubmed
** Filipits, M; Rudas, M; Heinzl, H; Jakesz, R; Kubista, E; Lax, S; Schippinger, W; Dietze, O; Greil, R; Stiglbauer, W; Kwasny, W; Nader, A; Stierer, M; Gnant, MF; Austrian Breast and Colorectal Cancer Study Group
Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy.
Clin Cancer Res. 2009; 15(18):5888-5894
Doi: 10.1158/1078-0432.CCR-09-0728
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gnant, M; Mlineritsch, B; Schippinger, W; Luschin-Ebengreuth, G; Pöstlberger, S; Menzel, C; Jakesz, R; Seifert, M; Hubalek, M; Bjelic-Radisic, V; Samonigg, H; Tausch, C; Eidtmann, H; Steger, G; Kwasny, W; Dubsky, P; Fridrik, M; Fitzal, F; Stierer, M; Rücklinger, E; Greil, R; ABCSG-12 Trial Investigators; Marth, C
Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
N Engl J Med. 2009; 360(7):679-691
Doi: 10.1056/NEJMoa0806285
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Dubsky, P; Sevelda, P; Jakesz, R; Hausmaninger, H; Samonigg, H; Seifert, M; Denison, U; Mlineritsch, B; Steger, G; Kwasny, W; Stöger, H; Bartsch, R; Stierer, M; Taucher, S; Fridrik, M; Schippinger, W; Greil, R; Pötter, R; Gnant, M; Austrian Breast and Colorectal Cancer Study Group
Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.
Clin Cancer Res. 2008; 14(7):2082-2087
Doi: 10.1158/1078-0432.CCR-07-2068
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Gnant, M; Mlineritsch, B; Luschin-Ebengreuth, G; Kainberger, F; Kässmann, H; Piswanger-Sölkner, JC; Seifert, M; Ploner, F; Menzel, C; Dubsky, P; Fitzal, F; Bjelic-Radisic, V; Steger, G; Greil, R; Marth, C; Kubista, E; Samonigg, H; Wohlmuth, P; Mittlböck, M; Jakesz, R; Austrian Breast and Colorectal Cancer Study Group (ABCSG)
Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy.
Lancet Oncol. 2008; 9(9):840-849
Doi: 10.1016/S1470-2045(08)70204-3
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Rudas, M; Lehnert, M; Huynh, A; Jakesz, R; Singer, C; Lax, S; Schippinger, W; Dietze, O; Greil, R; Stiglbauer, W; Kwasny, W; Grill, R; Stierer, M; Gnant, MF; Filipits, M; Austrian Breast and Colorectal Cancer Study Group
Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy.
CLIN CANCER RES. 2008; 14(6): 1767-1774.
Doi: 10.1158/1078-0432.CCR-07-4122
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Taucher, S; Steger, GG; Jakesz, R; Tausch, C; Wette, V; Schippinger, W; Kwasny, W; Reiner, G; Greil, R; Dubsky, P; Poestlberger, S; Tschmelitsch, J; Samonigg, H; Gnant, M; Austrian Breast and Colorectal Cancer Study Group-07
The potential risk of neoadjuvant chemotherapy in breast cancer patients--results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07).
Breast Cancer Res Treat. 2008; 112(2): 309-316.
Doi: 10.1007/s10549-007-9844-9
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Cataliotti, L; De Wolf, C; Holland, R; Marotti, L; Perry, N; Redmond, K; Del Turco, MR; Rijken, H; Kearney, N; Ellis, IO; Di Leo, A; Orecchia, R; Noel, A; Andersson, M; Audretsch, W; Bjurstam, N; Blamey, RW; Blichert-Toft, M; Bosmans, H; Burch, A; Bussolati, G; Christiaens, MR; Colleoni, M; Cserni, G; Cufer, T; Cush, S; Damilakis, J; Drijkoningen, M; Ellis, P; Foubert, J; Gambaccini, M; Gentile, E; Guedea, F; Hendriks, J; Jakesz, R; Jassem, J; Jereczek-Fossa, BA; Laird, O; Lartigau, E; Mattheiem, W; O'Higgins, N; Pennery, E; Rainsbury, D; Rutgers, E; Smola, M; Van Limbergen, E; von Smitten, K; Wells, C; Wilson, R
Guidelines on the standards for the training of specialised health professionals dealing with breast cancer
EUR J CANCER. 2007; 43(4): 660-675.
Doi: 10.1016/j.ejca.2006.12.008
Web of Science
FullText
FullText_MUG
** Koch, H; Kowatsch, E; Hödl, S; Smola, MG; Radl, R; Hofmann, T; Scharnagl, E
Verrucous carcinoma of the skin: long-term follow-up results following surgical therapy.
Dermatol Surg. 2004; 30(8):1124-1130
Doi: 10.1111/j.1524-4725.2004.30338.x
Web of Science
PubMed
FullText
FullText_MUG
** Taucher, S; Salat, A; Gnant, M; Kwasny, W; Mlineritsch, B; Menzel, RC; Schmid, M; Smola, MG; Stierer, M; Tausch, C; Galid, A; Steger, G; Jakesz, R; Austrian Breast and Colorectal Cancer Study Group
Impact of pretreatment thrombocytosis on survival in primary breast cancer.
Thromb Haemost. 2003; 89(6):1098-1106
Doi: 10.1267/THRO03061098
Web of Science
PubMed
FullText
FullText_MUG
** May, C; Smola, M; Ruda, C; Scharnagl, E
Randomized open controlled clinical study on the efficacy and tolerance of an oral enzyme preparation in lymphadenectomy patients
INT J IMMUNOTHER 2001 17: 149-152.
Web of Science
** Kronberger, L; Steinschifter, W; Weblacher, M; Estelberger, W; Liebmann, PM; Rabl, H; Smola, M; Lax, SF; Mischinger, HJ; Schauenstein, E; Schauenstein, K
Selective decrease of serum immunoglobulin G1 as marker for early stages of invasive breast cancer.
Breast Cancer Res Treat. 2000; 64(2):193-199
Doi: 10.1023/A:1006450205698
Web of Science
PubMed
FullText
FullText_MUG
** Blichert-Toft, M; Smola, MG; Cataliotti, L; O'Higgins, N
Principles and guidelines for surgeons--management of symptomatic breast cancer. On behalf of the European Society of Surgical Oncology.
Ann Chir Gynaecol. 1998; 87(1):101-109
Doi: 10.1016/S0748-7983(97)80001-7
PubMed
FullText
FullText_MUG
** O'Higgins, N; Linos, DA; Blichert-Toft, M; Cataliotti, L; de Wolf, C; Rochard, F; Rutgers, EJ; Roberts, PJ; Mattheiem, W; da Silva, MA; Holmberg, L; Schulz, KD; Smola, MG; Mansel, RE
European guidelines for quality assurance in the surgical management of mammographically detected lesions. European Breast Cancer Working Group.
Ann Chir Gynaecol. 1998; 87(1):110-112
Doi: 10.1016/S0748-7983(98)91329-4
Web of Science
PubMed
FullText
FullText_MUG
** O'Higgins, N; Linos, DA; Blichert-Toft, M; Cataliotti, L; de Wolf, C; Rochard, F; Rutgers, EJ; Roberts, P; Mattheiem, W; da Silva, MA; Holmberg, L; Schulz, KD; Smola, MG; Mansel, RE
European guidelines for quality assurance in the surgical management of mammographically detected lesions.
Eur J Surg Oncol. 1998; 24(2):96-98
Doi: 10.1016/S0748-7983(98)91329-4
Web of Science
PubMed
FullText
FullText_MUG
** Cerwenka, H; Hoff, M; Rosanelli, G; Hauser, H; Thalhammer, M; Smola, MG; Klimpfinger, M
Experience with a high speed biopsy gun in breast cancer diagnosis.
Eur J Surg Oncol. 1997; 23(3):206-207
Doi: 10.1016/S0748-7983(97)92268-X
Web of Science
PubMed
FullText
FullText_MUG
** Blichert-Toft, M; Smola, MG; Cataliotti, L; O'Higgins, N
Principles and guidelines for surgeons--management of symptomatic breast cancer. European Society of Surgical Oncology.
Eur J Surg Oncol. 1997; 23(2):101-109
Doi: 10.1016/S0748-7983(97)80001-7
Web of Science
PubMed
FullText
FullText_MUG
** Smola, MG
Breast neoplasms.
Osterr Krankenpflegez. 1996; 49(12):32-35
PubMed
** Bauernhofer, T; Stöger, H; Schmid, M; Smola, M; Gürtl-Lackner, B; Höfler, G; Ranner, G; Reisinger, E; Samonigg, H
Sequential treatment of recurrent mesenteric desmoid tumor.
Cancer. 1996; 77(6):1061-1065
Doi: 10.1002/(SICI)1097-0142(19960315)77:6<1061::AID-CNCR9>3.0.CO;2-K
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Hauser, H; Beham, A; Steindorfer, P; Schmidt, F; Smola, MG
Malignant schwannoma of the breast.
Langenbecks Arch Chir. 1995; 380(6):350-353
Doi: 10.1007/BF00207224
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Smola, MG; Ratschek, M; Amann, W; Samonigg, H; Mayer, R
The impact of resection margins in the treatment of primary sarcomas of the breast. A clinicopathological study of 8 cases with review of literature.
Eur J Surg Oncol. 1993; 19(1):61-69
PubMed
Google Scholar
** Hauser, H; Beham, A; Steindorfer, P; Smola, MG; Fruhwirth, H; Klimpfinger, M
Breast cancer in the catchment area of the Graz Institute of Pathology. Evaluation of morphologic parameters based on 1,510 cases.
Wien Klin Wochenschr. 1992; 104(23):717-720
Web of Science
PubMed
** Smola, MG; Ratschek, M; Hoflehner, H
A rare tumor of the sciatic nerve--myxoid neurofibroma. A case report.
Handchir Mikrochir Plast Chir. 1992; 24(2):84-87
(- Case Report)
PubMed
Google Scholar
** Lind, P; Lechner, P; Hausmann, B; Smola, MG; Koeltringer, P; Steindorfer, P; Cesnik, H; Passl, R; Eber, O
Development of Human Antimouse Antibodies (Hama) After Single and Repeated Diagnostic Application of Intact Murine Monoclonal-Antibodies
ANTIBODY IMMUNOCONJ RADIOPHAR. 1991; 4: 811-818.
Web of Science
Google Scholar
** Lind, P; Smola, MG; Lechner, P; Ratschek, M; Klima, G; Költringer, P; Steindorfer, P; Eber, O
The immunoscintigraphic use of Tc-99m-labelled monoclonal anti-CEA antibodies (BW 431/26) in patients with suspected primary, recurrent and metastatic breast cancer.
Int J Cancer. 1991; 47(6):865-869
Doi: 10.1002/ijc.2910470613
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Samonigg, H; Stöger, H; Kasparek, AK; Schmid, M; Dusleag, J; Pfeiffer, K; Smola, M; Steindorfer, P; Lechner, P
Prednimustine combined with mitoxantrone and 5-fluorouracil for first and second-line chemotherapy in advanced breast cancer.
Cancer Chemother Pharmacol. 1991; 27(6):477-480
Doi: 10.1007/BF00685163
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Scharnagl, E; Smola, MG; Hellbom, BA; Pierer, G; Hoflehner, H
Scar tissue cancer: observations and results of 23 cases.
Langenbecks Arch Chir. 1991; 376(6):341-345
Doi: 10.1007/BF00186426
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Smola, MG; Estelberger, W; Reiter, M; Schauenstein, K; Schauenstein, E
Sigma S, a measure of reactive sulfur groups of immunoglobulin G, is a sensitive tumor marker discriminating different stages of breast cancer.
Cancer. 1991; 68(5):1026-1030
Doi: 10.1002/1097-0142(19910901)68:5<1026::AID-CNCR2820680520>3.0.CO;2-H
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Smola, MG; Ratschek, M; Hauser, H; Amann, W; Veith, G; Ruppitsch, U; Steindorfer, P
Nonpalpable Breast-Cancer - Histological Results After Preoperative Marketing of 397 Nonpalpable Breast-Lesions
ONKOLOGIE. 1991; 14: 518-523.
Doi: 10.1159/000217037
Web of Science
FullText
FullText_MUG
** Smola, MG; Soyer, HP; Scharnagl, E
Surgical treatment of dermatofibrosarcoma protuberans. A retrospective study of 20 cases with review of literature.
Eur J Surg Oncol. 1991; 17(5):447-453
Web of Science
PubMed
Google Scholar
** Samonigg, H; Kasparek, AK; Stöger, H; Schmid, M; Eber, B; Stark, G; Weinrauch, V; Pfeiffer, K; Smola, M; Steindorfer, P
4'-O-tetrahydropyranyl-doxorubicin in advanced breast cancer: a phase II study.
Cancer Chemother Pharmacol. 1990; 26(4):293-296
Doi: 10.1007/BF02897233
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Deutschmann, W; Smola, MG; Scharnagl, E; Beham, A
Stewart-Treves syndrome and lymphangiosarcoma.
Chirurg. 1988; 59(9):605-609
(- Case Report)
Web of Science
PubMed
** Smola, MG; Scharnagl, E; Deutschmann, W; Beham, A
Multiple symmetrical lipomatosis. A retrospective study of 14 cases and review of the literature.
Handchir Mikrochir Plast Chir. 1988; 20(5):234-238
PubMed